Monika Baier
Overview
Explore the profile of Monika Baier including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
565
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Watz H, Mailander C, May C, Baier M, Kirsten A
Pulm Pharmacol Ther
. 2016 Dec;
42:13-20.
PMID: 27940287
Background: Long-acting bronchodilators, including anticholinergics glycopyrronium and tiotropium, are central to symptomatic management of chronic obstructive pulmonary disease (COPD). In patients with moderate to severe COPD, glycopyrronium has demonstrated comparable...
2.
Bayas A, Schuh K, Baier M, Vormfelde S
Ther Adv Neurol Disord
. 2016 Sep;
9(5):378-88.
PMID: 27582893
Objectives: Approximately one in two patients with multiple sclerosis (MS) suffer from comorbid depression. The primary objective of this study was to evaluate the safety and tolerability of fingolimod and...
3.
Watz H, Mailander C, Baier M, Kirsten A
BMC Pulm Med
. 2016 Jun;
16(1):95.
PMID: 27301417
Background: Physical activity limitation is common in chronic obstructive pulmonary disease (COPD), and is associated with worse health status, and increased hospitalisation and mortality. Long-acting bronchodilators, either alone or in...
4.
Maass N, Schem C, Bauerschlag D, Tiemann K, Schaefer F, Hanson S, et al.
Oncology
. 2014 Aug;
87(5):300-10.
PMID: 25171229
Background: Imatinib is a tyrosine kinase inhibitor of BCR-ABL, ABL, PDGFR-α and -β, KIT, and DDR. In solid tumors, it inhibits proliferation and invasiveness and facilitates higher intratumoral cytotoxic drug...
5.
Hadji P, Kauka A, Ziller M, Birkholz K, Baier M, Muth M, et al.
Breast Cancer Res Treat
. 2014 Feb;
144(2):343-51.
PMID: 24519387
Endocrine therapy (ET) is a key treatment modality in hormone receptor positive (HR+) early breast cancer (BC) patients. Although the anticancer activity of adjuvant ET + zoledronic acid (ZOL) has...
6.
Fasching P, Jud S, Hauschild M, Kummel S, Schutte M, Warm M, et al.
BMC Cancer
. 2014 Feb;
14:66.
PMID: 24499441
Background: The objective of this prospectively randomized phase II trial (Trial registration: EUCTR2004-004007-37-DE) was to compare the clinical response of primary breast cancer patients to neoadjuvant therapy with letrozole alone...
7.
Schulz E, Fleischhaker C, Hennighausen K, Heiser P, Haessler F, Linder M, et al.
Atten Defic Hyperact Disord
. 2011 Mar;
2(3):133-8.
PMID: 21432599
Several extended-release methylphenidate medications are available for treatment of children with ADHD. Pharmacokinetic investigations suggest that the serum levels of methylphenidate are partially altered when the medication is taken without...
8.
Jubala C, Lamerato-Kozicki A, Borakove M, Lang J, Gardner L, Coffey D, et al.
Cancer Immunol Immunother
. 2008 Jun;
58(2):171-85.
PMID: 18523772
The survival of naive T cells is compromised in the absence of molecules encoded by the major histocompatibility complex (MHC) while antigen-experienced T cells survive. We hypothesized that survival pressures...
9.
Grazioli E, Zivadinov R, Weinstock-Guttman B, Lincoff N, Baier M, Wong J, et al.
J Neurol Sci
. 2007 Dec;
268(1-2):12-7.
PMID: 18054962
Multiple sclerosis is characterized by the dual pathological processes of inflammation and neurodegeneration. Conventional MRI techniques are considered the best tools for assessing and monitoring lesion burden and inflammation but...
10.
Helme D, Donohew R, Baier M, Zittleman L
J Health Commun
. 2007 Jun;
12(4):399-415.
PMID: 17558790
In recent years, research has shown that mass media can be used effectively either alone or in conjunction with interpersonal and institutional channels, such as schools. Much has yet been...